Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation

Blood

Volumn 90, Issue 5, 1997, Pages 2097-2102

  Torok Storb, Beverly ^a,b   Boeckh, Michael ^a   Hoy, Cynthia ^a   Leisenring, Wendy ^a   Myerson, David ^a   Gooley, Ted ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN;

ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; DEATH; GENETIC VARIABILITY; GENOTYPE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; VIRUS ISOLATION;

EID: 0030882885     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.5.2097     Document Type: Article

References (36)

1. Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM, Elfenbein GE, Gale RP, Gluckman E, Good RA, Rimm AA, Rozman C, Speck B, Bortin MM: Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 73:606, 1989
2. Apperley JF, Goldman JM: Cytomegalovirus: Biology, clinical features and methods for diagnosis. Bone Marrow Transplant 3:253, 1988
3. Bilgrami S, Almeida GD, Quinn JJ, Tuck D, Bergstrom S, Dainiak N, Poliquinn C, Ascensao JL: Pancytopenia in allogeneic marrow transplant recipients: Role of cytomegalovirus. Br J Haematol 87:357, 1994
4. Mutter W, Reddehase MJ, Busch FW, Bühring H-J, Koszinowski UH: Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med 167:1645, 1988
5. Wingard JR, Chen DY-H, Burns WH, Fuller DJ, Braine HG, Yeager AM, Kaiser H, Burke PJ, Graham ML, Santos GW, Saral R: Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 71:1432, 1988
6. Verdonck LF, de Gast GC, van Heughten HG, Nieuwenhuis HK, Dekker AW: Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation. Blood 78:844, 1991
7. Simmons P, Kaushansky K, Torok-Storb B: Mechanisms of a cytomegalovirus-mediated myelosuppression: Perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 87:1386, 1990
8. Sing GK, Ruscetti FW: Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 75:1965, 1990
9. Duncombe AS, Grundy JE, Prentice HG, Brenner MK: IL2 activated killer cells may contribute to cytomegalovirus induced marrow hypoplasia after bone marrow transplantation. Bone Marrow Transplant 7:81, 1991
10. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St. Jeor SC: Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170, 1992
11. Apperley JF, Dowding C, Hibbin J, Buiter J, Matutes E, Sissons PJ, Gordon M, Goldman JM: The effect of cytomegalovirus on hemopoiesis: In vitro evidence for selective infection of marrow stromal cells. Exp Hematol 17:38, 1989
12. Kondo K, Kaneshima H, Mocarski ES: Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci USA 91:11879, 1994
13. Lagneaux L, Delforge A, Snoeck R, Bosmans E, Moreau JF, Taupin JL, De Clercq E, Stryckmans P, Bron D: Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells. Blood 87:59, 1996
14. Chou S, Dennison KM: Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 163:1229, 1991
15. Cranage MP, Kouzarides T, Bankier AT, Satchwell S, Weston K, Tomlinson P, Barrell B, Hart H, Bell SE, Minson AC, Smith GL: Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccination virus. EMBO J 5:3057, 1987
16. Cai WH, Gu B, Person S: Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J Virol 62:2596, 1988
17. Rasmussen L, Matkin C, Spaete R, Pachl C, Merigan TC: Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. J Infect Dis 164:835, 1991
18. Fries BC, Chou S, Boeckh M, Torok-Storb B: Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 169:769, 1994
19. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R: Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 174:184, 1996
20. Bongarts A, von Laer D, Vogelberg C, Ebert K, van Lunzen J, Garweg J, Vaith P, Hufert FT, Haller O, Meyer-König U: Glycoprotein B genotype of human cytomegalovirus: Distribution in HIV-infected patients. Scand J Infect Dis 28:447, 1996
21. Vogelberg C, Meyer-König U, Hufert FT, Kirste G, von Laer D: Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J Med Virol 50:31, 1996
22. Mathey B, Storb R: Allogeneic bone marrow transplantation: Current problems and possible solutions, in Ross EC, Simon TL, Moss GS, Gould SA (eds): Principles of Transfusion Medicine (ed 2). Baltimore, MD, Williams & Wilkins, 1995, p 493
23. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD, Clift R, Doney K, Martin PJ, Mickelson E, Nisperos B, O'Quigley J, Ramberg R, Sanders JE, Stewart P, Storb R, Sullivan KM, Witherspoon RP, Thomas ED, Hansen JA: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 320:197, 1989
24. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY: Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 323:1818, 1990
25. Beatty PG, Clift RA, Mickelson EM, Nisperos B, Flournoy N, Martin PJ, Sanders JE, Stewart P, Buckner CD, Storb R, Thomas ED, Hansen JA: Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313:765, 1985
26. Kernan NA, Bordignon C, Heller G, Cunningham I, Castro-Malaspina H, Shank B, Flomenberg N, Burns J, Yang SY, Black P, Collins NH, O'Reilly RJ: Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 74:2227, 1989
27. Storb R, Weiden PL, Sullivan KM, Appelbaum FR, Beatty P, Buckner CD, Clift RA, Doney KC, Hansen J, Martin PJ, Sanders JE, Stewart P, Witherspoon RP, Thomas ED: Second marrow transplants in patients with aplastic anemia rejecting the first graft: Use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood 70:116, 1987
28. Bolger GB, Sullivan KM, Storb R, Witherspoon RP, Weiden PL, Stewart P, Sanders J, Meyers JD, Martin PJ, Doney KC, Deeg HJ, Clift RA, Buckner CD, Appelbaum FR, Thomas ED: Second marrow infusion for poor graft function after allogeneic marrow transplantation. Bone Marrow Transplant 1:21, 1986
29. Bjerke JW, Lorenz J, Martin PJ, Storb R, Hansen JA, Anasetti C: Treatment of graft failure with anti-CD3 antibody BC3, glucocorticoids and infusion of donor hematopoietic cells. Blood 86:107a, 1995 (abstr, suppl 1)
30. Nemunaitis J, Singer JW, Buckner CD, Dumam D, Epstein C, Hill R, Storb R, Thomas ED, Appelbaum FR: Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood 76:245, 1990
31. Sierra J, Terol MJ, Urbano-Ispizua A, Rovira M, Marin P, Carreras E, Batlle M, Rozman C: Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation. Exp Hematol 22:566, 1994
32. Spencer A, Brookes PA, Kaminski E, Hows JM, Szydlo RM, van Rhee F, Goldman JM, Batchelor JR: Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Transplantation 59:1302, 1995
33. Torok-Storb B, Simmons P, Khaira D, Stachel D, Myerson D: Cytomegalovirus and marrow function. Ann Hematol 64:A128, 1992
34. Holmberg LA, Seidel K, Leisenring W, Torok-Storb B: Aplastic anemia: Analysis of stromal cell function in long-term marrow cultures. Blood 84:3685, 1994
35. Torok-Storb B, Holmberg L: Role of marrow microenvironment in engraftment and maintenance of allogeneic hematopoietic stem cells. Bone Marrow Transplant 14:871, 1994 (suppl 4)
36. Torok-Storb B, Simmons P, Barge A, Kaushansky K, Migliaccio AR, Johnson G: Mechanisms of marrow graft failure, in Sachs L, Abraham NG, Wiedermann CJ, Levine AS, Konwalinka G (eds): Molecular Biology of Haematopoiesis. Andover, Hampshire, Intercept, 1990, p 589